The Earth Times Online Newspaper (Free subscription) | 08/17/2009
CHICAGO - Fitch Ratings has assigned an 'A' rating to Baxter International Inc's. (Baxter) proposed debt offering of 10-year senior unsecured notes. Baxter intends to use the net proceeds from the sale for general corporate purposes, including the refinancing of outstanding indebtedne
Medical News Today (Free subscription) | 08/06/2009
Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations. CELVAPAN, the brand name for the company's A/H1N1 pandemic influenza vaccine, is made using Baxter's proprietary...
Palscience (Free subscription) | 08/06/2009
Pharmaceutical companies around the world are racing to produce H1N1 vaccine before the next flu season starts this fall. One of the leading pharmaceutical companies Baxter International Inc announced today that they have the vaccine ready for distribution. The H1N1 vaccine to be sold under the brand name Celvapan, made using Baxter’s cell culture process, which is [...]
Chicago Tribune (Free subscription) | 08/05/2009
Baxter International Inc. on Wednesday said it has completed production of the first batches of its swine flu vaccine and has begun discussing distribution plans with certain national health programs.
The Earth Times Online Newspaper (Free subscription) | 08/05/2009
DEERFIELD, Ill. - Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate
Business Wire (Free subscription) | 08/05/2009
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing
Market Watch (Free subscription) | 07/28/2009
NEW YORK (MarketWatch) -- Baxter International Inc. said Tuesday that its board authorized the buyback of an additional $2 billion of company stock. The health-care company said it has less than $300 million remaining under its previous $2 billion share-repurchase authorization from March 2008. Baxter also declared a quarterly dividend of 26 cents a share, in line with its current rate. Market Pulse...
Business Wire (Free subscription) | 07/28/2009
DEERFIELD, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.26 per share of Baxter common stock. This payment represents a continuation of
Chicago Tribune (Free subscription) | 07/27/2009
Atty. Gen. Lisa Madigan today said her office has won a $6.8 million settlement with Deerfield-based medical product giant Baxter International Inc., which had been accused of inflating prices of drugs used by poor patients to the state of Illinois.
Business Wire (Free subscription) | 07/23/2009
CHICAGO--(BUSINESS WIRE)--Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock
SeekingAlpha.com (Free subscription) | 07/17/2009
Andrew Corn submits: March 2008, the U.S. Food and Drug Administration was forced to recall the drug Heparin after a number of deaths were linked to the product’s use. According to the agency, the root of the problem was traced to contaminated Chinese factories that supplied the raw materials needed to manufacture the popular blood thinner. By the time the recall ended, the Heparin contamination...
Forex Analytics (Free subscription) | 07/16/2009
DEERFIELD, Illinois—-Baxter International Inc. heute meldete starke Finanzergebnisse während of Zweiten Quartals von 2009 und warf the Seine Volljahr Finanzaussicht auf. More: continued here (c)Autor: Forex Analytics Blog: earn money with Forex convert this post to pdf.Post from: (c)Autor: Forex Analytics Baxter de rapport Strong Second Quarter 2009 Financial Results and Raises Full-Year...
VitaBeat (Free subscription) | 07/16/2009
Baxter International Inc. (NYSE:BAX) Thursday reported strong financial results as the second-quarter profit jumped by 8 percent, topping market economist estimates. The firm has also raised its full-year financial outlook for 2009. For the full year, the biggest maker of treatments for blood disorders continues to expect sales growth, excluding the impact of foreign currency, to be between 7 percent...
Daily Advance - Business (Free subscription) | 07/16/2009
DEERFIELD, Ill. — Specialty drug and medical device maker Baxter International Inc. said Thurs...
Financial24 (Free subscription) | 07/16/2009
CHICAGO, July 16 - Baxter International Inc: Says should be ready to ship h1n1 vaccines by end of july/early August Says has 5 orders for 80 million doses of h1n1 vaccine Says not in a position to take more h1n1 vaccines orders Says pre ...
Videos